Christian M Vonk
4PUBLICATIONS
22CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jul 17, 2025
Utility of IDH1/2 mutations as biomarkers for detection of measurable residual disease in acute myeloid leukemia.Emma L Boertjes, Christian M Vonk, François G Kavelaars
|Dec 05, 2024
Advantages of a genomic DNA-based next-generation sequencing assay for detection of mutant NPM1 measurable residual disease in AML.Christian M Vonk, Tim Grob, Melissa Rijken
|Sep 04, 2024
Risk Stratification in Older Intensively Treated Patients With AML.Jurjen Versluis, Marlen Metzner, Ariel Wang
|Aug 16, 2024
Prognostic relevance of molecular measurable residual disease detection in AML with mutated CEBPA.Christian M Vonk, Emma L Boertjes, Francois G Kavelaars
Pageof 1
Frequent Collaborators
3 joint publications
Bob Löwenberg
2 joint publications
Emma L Boertjes
2 joint publications
Markus Manz
1 joint publications
Jurjen Versluis
1 joint publications
Marlen Metzner
1 joint publications
Ariel Wang
1 joint publications
Abin Thomas
1 joint publications
Niels Asger Jakobsen
1 joint publications
Alison Kennedy
1 joint publications
Amanda Gilkes
